Group 1 - The insurance sector is currently leading the A-share market rally, with significant gains observed on July 28, 2023, where stocks like New China Life and China Pacific Insurance rose over 4%, while China Life and Ping An increased by more than 3% [2] - The recent surge in insurance stocks is attributed to improved performance driven by increased insurance awareness among residents and a growing demand for insurance products, which has positively impacted premium income [3] - Analysts predict that the upward trend in insurance stocks will continue, supported by strong market savings demand and a gradual decrease in liability costs due to regulatory guidance and proactive transformations by insurance companies [4][5] Group 2 - The valuation of insurance stocks is recovering, with many stocks reaching new highs, indicating potential for further growth in the future [4] - The investment side of insurance companies is expected to benefit from rising long-term interest rates, which could alleviate pressure on new fixed-income investment yields [5] - Analysts forecast that the upcoming semi-annual reports will show continued growth in new business value for life insurance, with increasing demand for health and pension insurance, while property insurance profitability is also expected to improve [5]

Group 1: Insurance Sector Insights - The recent adjustment in the predetermined interest rate for life insurance is expected to alleviate the pressure of interest rate losses, maintaining an "overweight" rating for the industry [2][5][24] - The insurance industry association has announced a new predetermined interest rate of 1.99%, triggering a mechanism for rate adjustments, with major insurers planning to switch to new products by September [3][4][22] - The adjustment of the predetermined interest rates is anticipated to improve the cost of liabilities, with a focus on transforming towards floating income products [4][24] Group 2: Fixed Income Market Analysis - The bond market has experienced significant fluctuations due to various factors, including tightening liquidity and rising commodity prices, leading to a notable decline in bond prices [7][9] - The current high duration and leverage in the bond market limit the strategic flexibility of investors, making them more vulnerable to market volatility [8] - The recent rise in commodity prices poses a greater threat to the bond market than previous stock market gains, as it contradicts the fundamental pricing of bonds [9] Group 3: Investment Recommendations - The report suggests increasing holdings in major insurance companies such as New China Life, China Life, China Pacific Insurance, and Ping An Insurance due to expected improvements in profitability and asset-liability matching [5][24] - The insurance sector is projected to see stable profit growth in the first half of 2025, driven by a recovery in the stock and bond markets [22][24] - The report emphasizes the importance of focusing on undervalued insurance stocks for potential valuation recovery opportunities [24]

7月28日，A股三大指数全天震荡反弹，截至收盘，沪指涨0.12%，深证成指涨0.44%，创业板指涨 0.96%，再创年内新高。当前市场处在关键点位，保险股成为扛起这一轮上涨的牛市旗手。当日，A股 市场保险股全线爆发。截至北京商报记者发稿，新华保险、中国太保涨幅均超4%，中国人寿、中国平 安涨幅也超过了3%。实际上，近几个月来，保险股不止一次领涨A股，累计涨幅明显。在A股三大股指 上扬的同时，若聚焦细分板块来看，保险、制药、电子元器件等多个行业指数均明显上涨，同期，被称 为"牛市旗手"的券商股、银行股也表现亮眼。 保险 "保险股非常符合价值投资需求，业绩好、分红高，且险企资产稳定，对绝大部分资管机构有吸引力； 此外，随着A股估值整体提升，保险股也将受益。"王兆江总结道。 从机构的角度来说，未来保险股也有望获得基金等机构加仓。国金证券表示，在《推动公募基金高质量 发展行动方案》文件精神之下，为了不跑输基准，未来主动基金可能会选择配置基准内权重较高的行 业，而包括保险行业在内的非银板块显著低配，未来有望成为主动基金增配的行业。 券商 业绩改善推动估值回升 7月28日，A股市场保险股集体走强。截至北京商报记者发稿，新 ...

Core Viewpoint - The recent surge in insurance capital's significant stake acquisitions in the secondary market reflects a shift towards long-term value investment strategies, driven by declining interest rates, regulatory encouragement, and asset-liability management needs [1][2]. Group 1: Insurance Capital Activity - As of July 28, 2025, insurance companies have completed 21 stake acquisitions, surpassing the total for 2024 and setting a five-year record, with major players including Ping An Life, China Post Insurance, and New China Life [1]. - Ping An Life and its affiliated asset management companies have been the primary force behind these acquisitions, triggering seven stake purchases, including three for China Merchants Bank H-shares, increasing their holding from 5% to 15% [1]. Group 2: Investment Rationale - The frequent buying of state-owned bank H-shares by insurance capital is a strategic decision based on factors such as dividend yield, tax advantages, market liquidity, regulatory requirements, and counter-cyclical attributes [2]. - Stake acquisitions allow insurance companies to optimize financial statements and mitigate the impact of market volatility by accounting for investment income using the equity method [2]. Group 3: Asset Allocation Trends - As of Q1 2025, the proportion of stocks and funds in domestic insurance capital reached a historical high of 13.3%, indicating a strong desire among insurance companies to increase equity investments due to declining yields in bonds and non-standard assets [3]. - New China Life has shown a strong commitment to increasing its equity asset ratio, which reached nearly 20% in 2024, with a further increase of 2 percentage points in the first half of 2025 [3]. Group 4: Regulatory Support - The regulatory framework is encouraging long-term equity investments by insurance capital, with a recent notice from the Ministry of Finance introducing a five-year cycle indicator for assessing the performance of insurance funds [4]. - The new assessment method adjusts the evaluation of net asset return rates and capital preservation rates to include annual, three-year, and five-year indicators, promoting stability and sustainability in long-term investments [4].

Core Viewpoint - The 2024 life insurance industry has seen a decline in employee compensation and a historical low in the salary-to-premium ratio, indicating potential challenges in operational efficiency and profitability [2][14]. Group 1: Salary and Premium Ratio Analysis - In 2024, the total employee compensation in the life insurance industry was 108.5 billion yuan, a decrease of 4.6% year-on-year, with a salary-to-premium ratio of 3.4%, down 0.5 percentage points, marking a 15-year low [2][14]. - The "TOP7+1" companies (including major players like China Life and Ping An) had a salary-to-premium ratio of 3.3%, which is significantly lower than that of small and medium-sized insurance companies, which stood at 3.7% [17][18]. - The average salary-to-premium ratio for 70 life insurance companies over the past five years was 4.0%, with a median of 4.9%, and 11 companies exceeding 10% [5][28]. Group 2: Impact on Return on Equity (ROE) - The salary-to-premium ratio has a significant negative impact on a company's ROE, with each 1 percentage point increase in the ratio leading to a 0.37 percentage point decrease in ROE [24][25]. - The empirical model constructed to analyze this relationship included variables such as company size and channel type, confirming the negative correlation between salary-to-premium ratio and ROE [24][25]. Group 3: Historical Trends - The salary-to-premium ratio has shown a declining trend since 2018, with a notable acceleration in the decline for small and medium-sized insurance companies since 2019 [16][18]. - The ratio increased from 4.2% in 2010 to a peak of 5.3% in 2015, followed by a steady decline to the current levels [16][18]. Group 4: Employee Compensation Insights - The life insurance industry employed approximately 345,000 individuals in 2023, with an average compensation and benefits level of 330,000 yuan [10][22]. - The fluctuation in employee numbers has shown a slight decline, while average compensation has seen minor increases over recent years [10][22].

Group 1 - Heng Rui Pharmaceutical experienced a significant stock surge of 24.54%, closing at HKD 84.75 per share, following an announcement of a licensing agreement with GlaxoSmithKline (GSK) [11] - The agreement grants GSK global exclusive rights to the HRS-9821 project and options for up to 11 additional projects, excluding certain regions in China [11] - GSK will pay Heng Rui Pharmaceutical an upfront fee of USD 500 million, with potential milestone payments totaling up to USD 12 billion if all projects are successfully developed and commercialized [11] Group 2 - The Hong Kong stock market showed mixed results, with the Hang Seng Index rising by 0.68% to 25,562.13 points, while the Hang Seng Technology Index fell by 0.24% [2][3] - The overall market turnover reached HKD 250.3 billion, with net inflows from southbound trading amounting to HKD 9.25 billion [2] - Pharmaceutical stocks performed strongly, with the oncology index leading gains at 9.17% and the innovative drug index rising by 7.5% [3]

Core Viewpoint - 恒瑞医药's record-breaking overseas licensing deal has significantly boosted its stock price, leading to a 24.54% increase in Hong Kong shares [15][16]. Market Overview - On July 28, the Hong Kong stock market showed mixed results, with the Hang Seng Index rising by 0.68% to 25,562.13 points, while the Hang Seng Technology Index fell by 0.24% to 5,664.02 points. The total market turnover was HKD 250.3 billion, with net inflows from southbound funds amounting to HKD 9.253 billion [2][3]. Pharmaceutical Sector Performance - The pharmaceutical sector experienced a strong rally, with the anti-tumor index leading gains at 9.17% and the innovative drug index rising by 7.5% [4]. Insurance Sector Highlights - Insurance stocks showed robust performance, with China Ping An reaching a high of HKD 57.65 per share, marking a nearly 6% increase and a year-to-date rise of 22.70%. The industry is optimistic following a recent meeting that assessed the valuation interest rate for life insurance products at 1.99% [6][9]. AIA Group Insights - AIA Group's new business value (VNB) is expected to grow by 19% in the first half of the year, driven by strong performance in Hong Kong. Morgan Stanley anticipates that key financial metrics will remain strong despite market volatility [9]. Alibaba Developments - Alibaba's stock rose by 2.20% on July 28, with a cumulative increase of 7.47% in July. The founder of Alibaba Cloud expressed concerns that about 90% of current AI technologies may become obsolete within the next decade [11][14]. Heng Rui Pharmaceutical Licensing Agreement - Heng Rui Pharmaceutical's stock surged after announcing a licensing agreement with GlaxoSmithKline (GSK) for the global exclusive rights to the HRS-9821 project and up to 11 additional projects. GSK will pay Heng Rui a USD 500 million upfront fee, with potential milestone payments totaling up to USD 12 billion if all projects are successfully developed and commercialized [16].

Core Viewpoint - The insurance sector is leading the current market rally, with significant gains in stock prices for major companies like Xinhua Insurance and China Life, indicating a strong performance in the A-share market [1][3][4]. Group 1: Market Performance - On July 28, insurance stocks in the A-share market surged, with Xinhua Insurance and China Pacific Insurance rising over 4%, while China Life and Ping An increased by more than 3% [3][4]. - In the Hong Kong market, insurance stocks also performed well, with Xinhua Insurance's stock rising by as much as 7% [4]. - Year-to-date, Xinhua Insurance has increased by over 34%, Ping An by over 17%, China Life by over 3%, and China Pacific Insurance by over 14% [4]. Group 2: Factors Driving Growth - The recent surge in insurance stocks is attributed to improved performance and valuation recovery, driven by increased public awareness of insurance and rising premium income [4][5]. - The insurance sector's investment performance has also benefited from the stock market's recovery since September of the previous year, enhancing overall earnings [4][5]. - The latest traditional insurance preset interest rate research value is 1.99%, which has triggered conditions for a potential rate adjustment, indicating a favorable environment for the sector [4]. Group 3: Future Outlook - Analysts believe that insurance stocks still have growth potential, supported by strong savings demand and a gradual decrease in liability costs due to regulatory guidance and proactive transformation by insurance companies [5][6]. - The recent rise in the ten-year government bond yield to approximately 1.73% may alleviate pressure on new fixed-income investment returns for insurance companies as the economy recovers [5]. - The upcoming half-year reports are expected to show continued growth in new business value for life insurance, with increasing demand for health and pension insurance, and stable profitability in property insurance [5][6].

Core Viewpoint - The insurance sector in the A-share market experienced a significant surge, with major companies like Xinhua Insurance, China Pacific Insurance, and China Life Insurance seeing substantial gains, driven by favorable regulatory changes regarding insurance product interest rates [1][4]. Group 1: Market Performance - As of July 28, Xinhua Insurance's stock price rose by 4.72% to 66.80, while China Pacific Insurance and China Life Insurance also saw increases of 4.00% and 2.89% respectively [2]. - In the Hong Kong market, Yunfeng Financial surged over 7%, and AIA Group rose nearly 5%, with other major insurers following suit [3]. Group 2: Regulatory Changes - The China Insurance Industry Association indicated that the current benchmark interest rate for ordinary life insurance products is set at 1.99%, triggering a necessary adjustment in the maximum preset interest rates for new products [4]. - Major insurers like China Life, Ping An Life, and China Pacific Life have already announced reductions in their traditional life insurance product rates from 2.5% to 2.0%, and the guaranteed rate for participating insurance has been adjusted from 2% to 1.75% [4]. Group 3: Industry Outlook - Analysts predict that the adjustment in preset interest rates will alleviate the pressure on insurers' interest margins and lower liability costs, enhancing the profitability of new business [5]. - The dynamic adjustment mechanism for preset interest rates is expected to improve the liability costs and net investment returns for life insurance companies, thereby reducing asset allocation pressures and interest margin risks [5]. Group 4: Anti-Competition Measures - The insurance industry has been receiving signals to combat "involution," with the central government emphasizing the need to regulate low-price competition [6]. - The Guangdong financial sector has taken steps to prevent "involution" by issuing self-regulatory agreements to resist malicious price wars and ensure fair competition [6]. Group 5: Future Prospects - Analysts from CITIC Securities believe that regulatory guidance will encourage the development of participating insurance, allowing leading insurers to achieve healthy balance sheet expansion while reducing liability costs [7]. - The market outlook remains optimistic, with expectations of continued growth in new business value (NBV) for life insurers and significant improvements in the combined operating ratio (COR) for property insurers [7].

Group 1: Hong Kong Stock Market Highlights - New China Life Insurance (01336) rose over 5%, reaching a historical high, while China Life (2628.HK) increased by 4.4%, AIA (1299.HK) by 3.5%, and China Pacific Insurance (2601.HK) by nearly 2% following the release of the 2Q25 predetermined interest rate of 1.99% by the insurance industry association [1] - Heng Rui Pharmaceutical (1276.HK) opened up 10.65% after announcing a global exclusive licensing agreement with GSK for the HRS-9821 project, excluding mainland China and certain regions [1] - Guangshen Railway (00525.HK) saw a peak increase of over 9% after signing a cooperation agreement for the Guangzhou East Station renovation project, with a total investment of approximately 16.66 billion yuan [1] Group 2: Other Notable Stock Movements - MicroPort Medical (00853.HK) surged over 8% as major shareholders agreed to sell a total of 291 million shares to various buyers, including funds under Shanghai Industrial Capital [2] - China Tobacco Hong Kong (06055.HK) rose over 5% following the release of a draft management regulation for domestic duty-free tobacco products by the National Tobacco Monopoly Administration [2] - Shenghua Land (08106) saw its stock price soar over 200% after a share acquisition agreement was reached [2] - Jiufang Zhitu Holdings (09636) increased over 10% after announcing a profit forecast for the first half of the year, expecting a net profit of 830 to 870 million yuan, a turnaround from a net loss of 174 million yuan in the same period last year [2] - Lianlian Digital (02598) rose over 7% as a report highlighted the significant role of third-party payment institutions in cross-border and multi-currency settlement services [2] Group 3: Macau Gaming Sector Performance - Gaming stocks saw a general increase, with Amax Holdings (00880) up 10.39%, Melco International Development (00200) up 5.64%, and Sands China (01928) up 3.25%. UBS reported that the average daily gaming revenue in Macau for the past week was 657 million patacas, a slight decline due to typhoon impacts, but still showing a year-on-year growth of approximately 14% [3] Group 4: US Stock Market Highlights - AMD (AMD.US) rose 2.68% as it achieved a 50% market share in the server CPU market, matching Intel for the first time [4] - Newmont Corporation (NEM.US) increased by 6.89%, reporting a second-quarter earnings per share of $1.85, up from 73 cents year-on-year [5] - Berkshire Hathaway's holding Verisign (VRSN.US) rose 6.67% despite Q2 revenue falling short of market expectations, as the company raised its full-year revenue guidance [5] - Tesla (TSLA.US) increased by 3.52% with plans to launch Robotaxi services in San Francisco [6]